(Q33748913)

29 July 2017

1 reference

title

N-methyl-D-aspartate antagonists and drug discrimination (English)

1 reference

29 July 2017

Koek W

1

1 reference

29 July 2017

language of work or name

English

0 references

publication date

1 October 1999

1 reference

Pharmacology, Biochemistry and Behavior

29 July 2017

published in

1 reference

29 July 2017

volume

64

1 reference

29 July 2017

issue

2

1 reference

29 July 2017

page(s)

275-281

1 reference

Evaluation of the reinforcing effects of eliprodil in rhesus monkeys and its discriminative stimulus effects in rats

29 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2899%2900055-6

7 January 2021

Competitive and uncompetitiveN-methyl-d-aspartate antagonist discriminations in pigeons: CGS 19755 and phencyclidine

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2899%2900055-6

7 January 2021

Interactions between N-methyl-D-aspartate receptor antagonists and the discriminative stimulus effects of morphine in rats

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2899%2900055-6

7 January 2021

Stereoselective Antagonism of Phencyclidine's Discriminative Properties by Adenosine Receptor Agonists

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2899%2900055-6

7 January 2021

A specific alkylating ligand for phencyclidine (PCP) receptors antagonizes PCP behavioral effects

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2899%2900055-6

7 January 2021

Clozapine but not haloperidol antagonizes an MK-801 discriminative stimulus cue.

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2899%2900055-6

7 January 2021

Chemical dissociation of human awareness: focus on non-competitive NMDA receptor antagonists

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2899%2900055-6

7 January 2021

History and pharmacology of PCP and PCP-related analogs.

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2899%2900055-6

7 January 2021

Dizocilpine-like discriminative stimulus effects of competitive NMDA receptor antagonists in mice.

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2899%2900055-6

7 January 2021

Dizocilpine-like discriminative stimulus effects of low-affinity uncompetitive NMDA antagonists.

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2899%2900055-6

7 January 2021

Safety and tolerability of the glutamate antagonist CGS 19755 (Selfotel) in patients with acute ischemic stroke. Results of a phase IIa randomized trial

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2899%2900055-6

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2899%2900055-6

7 January 2021

Discriminative stimulus effects of glutamate release inhibitors in rats trained to discriminate ethanol.

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2899%2900055-6

7 January 2021

Is the discriminative stimulus produced by phencyclidine due to an interaction with N-methyl-D-aspartate receptors?

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2899%2900055-6

7 January 2021

Drug discrimination in rats: The effects of phencyclidine and ditran

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2899%2900055-6

7 January 2021

The involvement of sigma receptors in the choice reaction performance deficits induced by phencyclidine

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2899%2900055-6

7 January 2021

Failure of ibogaine to produce phencyclidine-like discriminative stimulus effects in rats and monkeys

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2899%2900055-6

7 January 2021

2-Amino-6-trifluoromethoxy benzothiazole (PK 26124), a proposed antagonist of excitatory amino acid neurotransmission, does not produce phencyclidine-like behavioral effects in pigeons, rats and rhesus monkeys.

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2899%2900055-6

7 January 2021

Psychotogenicity and N-methyl-D-aspartate receptor antagonism: implications for neuroprotective pharmacotherapy.

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2899%2900055-6

7 January 2021

The NMDA-receptor antagonist CPP abolishes neurogenic 'wind-up pain' after intrathecal administration in humans

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2899%2900055-6

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2899%2900055-6

7 January 2021

Neurochemical and Behavioral Aspects of Lamotrigine

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2899%2900055-6

7 January 2021

The glycine site on the NMDA receptor: structure-activity relationships and therapeutic potential

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2899%2900055-6

7 January 2021

Pharmacological specificity of the phencyclidine discriminative stimulus in rats

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2899%2900055-6

7 January 2021

A time-activity baseline to measure pharmacological and non-pharmacological manipulations of PCP-induced activity in mice

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2899%2900055-6

7 January 2021

Pharmacological effects of the non-competitive NMDA antagonist CNS 1102 in normal volunteers

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2899%2900055-6

7 January 2021

Effects of prolonged infusions of the NMDA antagonist aptiganel hydrochloride (CNS 1102) in normal volunteers.

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2899%2900055-6

7 January 2021

NE-100, a novel sigma receptor ligand: in vivo tests

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2899%2900055-6

7 January 2021

NE-100, a novel sigma receptor ligand: effect on phencyclidine-induced behaviors in rats, dogs and monkeys

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2899%2900055-6

7 January 2021

Behavioral evidence for modulation by sigma ligands of (+)MK-801-induced hyperlocomotion in monoamine-depleted mice.

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2899%2900055-6

7 January 2021

Effect of NE-100, a novel sigma receptor ligand, on phencyclidine-induced delayed cognitive dysfunction in rats

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2899%2900055-6

7 January 2021

Lack of amnestic, psychotomimetic or impairing effect on psychomotor performance of eliprodil, a new NMDA antagonist.

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2899%2900055-6

7 January 2021

The putative anti-addictive drug ibogaine is a competitive inhibitor of [3H]MK-801 binding to the NMDA receptor complex

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2899%2900055-6

7 January 2021

Clozapine attenuates N-methyl-D-aspartate receptor complex-mediated responses in vivo: tentative evidence for a functional modulation by a noradrenergic mechanism

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2899%2900055-6

7 January 2021

Pharmacotoxic psychosis after memantine in Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2899%2900055-6

7 January 2021

Effects of the novel NMDA-receptor antagonist SDZ EAA 494 on memory and attention in humans

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2899%2900055-6

7 January 2021

Therapeutic potential of excitatory amino acid antagonists: channel blockers and 2,3-benzodiazepines

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2899%2900055-6

7 January 2021

The excitatory amino acid antagonist D-CPP-ene (SDZ EAA-494) in patients with epilepsy

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2899%2900055-6

7 January 2021

A role for receptors of N-methyl-D-aspartic acid in the discriminative stimulus properties of phencyclidine.

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2899%2900055-6

7 January 2021

Phencyclidine-like discriminative stimulus properties of MK-801 in rats

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2899%2900055-6

7 January 2021

Neuropsychiatric adverse effects of antiparkinsonian drugs. Characteristics, evaluation and treatment

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2899%2900055-6

7 January 2021

10.1016/S0091-3057(99)00055-6

Identifiers

DOI

1 reference

29 July 2017

1 reference